Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Elevation Oncology
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
UNC Lineberger Comprehensive Cancer Center
University of Nebraska
Novartis
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
National Institutes of Health Clinical Center (CC)
Calithera Biosciences, Inc
University of Wisconsin, Madison
National Institutes of Health Clinical Center (CC)
Weill Medical College of Cornell University
Brown University
M.D. Anderson Cancer Center
University of Texas Southwestern Medical Center
PrECOG, LLC.
M.D. Anderson Cancer Center
Rutgers, The State University of New Jersey
University of Texas Southwestern Medical Center
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Wisconsin, Madison
Novartis
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
National Institutes of Health Clinical Center (CC)
Amgen
Medical University of South Carolina
Medical University of South Carolina
Dartmouth-Hitchcock Medical Center
Western Regional Medical Center
Dana-Farber Cancer Institute
Duke University
OHSU Knight Cancer Institute
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)